Announcements Trials
Browse Landscape

Phase

Phase 1 2Phase 4 1

Status

Completed 2Withdrawn 1

Sponsor Class

OTHER 3

Study Type

Interventional 3

Sponsor

Cancer Type

Gastrointestinal 23Breast 14Genitourinary 12Thoracic 9Head & Neck 7Dermatologic 6Other 4Gynecologic 4Lymphoid 3CNS 3Tumor-Agnostic 1Other hematologic neoplasm 1

Conditions

Neurofibromatoses 1Neoplasms 1Hydrocephalus 1Headache 1Glioblastoma 1Epilepsy 1Brain Neoplasms 1Abdominal Neoplasms 1

Interventions

Temozolomide 610Radiotherapy 388Bevacizumab 254Magnetic Resonance Spectroscopy 203Cyclophosphamide 177Carboplatin 159Radiosurgery 146Etoposide 132Radiation 121Irinotecan 115Vincristine 114Cisplatin 102Filgrastim 100Specimen Handling 88Nivolumab 87pembrolizumab 82Lomustine 81Topotecan 73Surgical Procedures, Operative 73Doxorubicin 60Melphalan 59Carmustine 57sargramostim 53Radiotherapy, Intensity-Modulated 53Isotretinoin 53Peripheral Blood Stem Cell Transplantation 52Granulocyte Colony-Stimulating Factor 50Erlotinib Hydrochloride 50Everolimus 48Chemotherapy, Adjuvant 48

Date Range

30 days90 days1 yearAll

Options

Has results Has announcements

Clinical Trials

3 trials
RecentStart dateEnrollment
Interventional × Lidocaine × CNS × Clear all
NCT04716699 2026-03-10

Systemic and Local Levels of Lidocaine During Surgery for the Removal of Glioblastoma

University of California, Davis

Phase 1 Completed
12 enrolled
CNS

Glioblastoma

NCT03177252 2020-10-22

Scalp block

Washington University School of Medicine

Phase 1 Withdrawn
CNS

Brain Neoplasms

NCT03513757 2020-02-21

Dexmedetomidine and Propofol for Pediatric MRI Sedation

Medical College of Wisconsin

Phase 4 Completed
40 enrolled 15 charts
CNS

Abdominal Neoplasms, Epilepsy, Headache, Hydrocephalus, Neoplasms, Neurofibromatoses

Data powered by HemOnc (CC BY 4.0) Colophon âš¡